- Home
- IXHL vs OPRX Comparison
IXHL vs OPRX Comparison
Compare IXHL & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IXHL | OPRX |
|---|---|---|
| Founded | 2001 | 2006 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Business Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.6M | 115.4M |
| IPO Year | 2024 | 2008 |
Fundamental Metrics
Financial Performance| Metric | IXHL | OPRX |
|---|---|---|
| Price | $2.89 | $6.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.67 |
| AVG Volume (30 Days) | ★ 3.1M | 438.5K |
| Earning Date | 05-14-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | N/A | ★ 0.27 |
| Revenue | $12,000.00 | ★ $109,429,000.00 |
| Revenue This Year | N/A | $3.88 |
| Revenue Next Year | N/A | $8.49 |
| P/E Ratio | ★ N/A | $25.13 |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $0.11 | $5.54 |
| 52 Week High | $6.39 | $22.25 |
Technical Indicators
Market Signals| Indicator | IXHL | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 51.32 | 42.74 |
| Support Level | $0.32 | $5.54 |
| Resistance Level | $5.17 | $14.28 |
| Average True Range (ATR) | 0.44 | 0.56 |
| MACD | -0.22 | 0.14 |
| Stochastic Oscillator | 0.62 | 51.02 |
Price Performance
Historical ComparisonAbout IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.